Payments for members votes were supposed to be a thing of the past at the International Olympic Committee but new allegations will prompt fresh scrutiny

Bungs and secret bank accounts; shadowy figures on the take and make; the bidding process for major sporting events shown to be as transparent as an oil slick. The script might appear stale given the numerous tales of scandals and scoundrels at Fifa and the IAAF, the global guardians of football and athletics respectively, in recent years. But now there is a fresh and intriguing twist.

The grandest sporting organisation of all, the International Olympic Committee (IOC), has stood aloof while the staggering tales of corruption surrounding World Cup and World Athletics Championships bids seeped out. We are different, the IOC insisted. We have reformed. And with few dissenting voices or evidence to the contrary, the bad old days of the late 90s, when members votes were bought for enormous sums during feverish races to host Olympic Games, had become a distant memory.

The IOCs bullishness was evident as recently as March, when the Guardian revealed that French police were investigating the bidding process for the 2020 Olympics. The IOC president, Thomas Bach, brushed away any concerns: The IOC has done as much as any organisation can do to address the issue of corruption, he insisted. We have all rules and instruments in place to fight corruption with zero tolerance.

Todays allegations should shatter that complacency. Two independent sources have told the Guardian that Tokyos successful bidding team for the 2020 Olympics, or those acting on their behalf, made payments of around 1.3m ($1.5m) to a hidden account linked to Papa Massata Diack, the former International Association of Athletics Federation (IAAF) marketing fixer who was recently banned from athletics for life. The orchestra of rules and instruments that Bach so proudly conducted have been unable to prevent an embarrassing cacophony.

Those with long memories will recall that Japan previously played fast and loose with the rules as did many other nations. Nagano won the right to host the 1998 Winter Games after providing IOC members with trips to luxury hot spring resorts, first-class air tickets, and geisha although they insisted no sexual favours were provided while the-then IOC president, Juan Antonio Samaranch, was put up in the top suite at the Hotel Kokusai 21, which the Nagano Olympic Committee rented for 30 days at $2,700 a night.

The largesse didnt end there. Nagano also provided millions of dollars in corporate contributions to help build an Olympic museum in Switzerland while the bidding race was going on. Mere coincidence, it claimed. All this was meticulously documented by its bid committee in a series of files that filled 10 large cardboard boxes. However when the focus turned on them, the papers were burned. As the bids former vice secretary-general Sumikazu Yamaguchi sheepishly explained: I didnt want the IOC members to be uncomfortable.

It took the Swiss lawyer Marc Hodler, an IOC member for 35 years, to blow the whistle on what was really going on. His initial exposure of the Salt Lake City scandal in 1998 eventually led to 10 members being either expelled or resigning amid allegations of bribes and offers of scholarships, medical care, dubious real estate deals and even sexual favours during the bidding process for the 2002 Winter Olympics. Hodler also revealed the scale of the sums on the table: bribes of up to $1m for IOC members and payoffs to agents of up of between $3m and $5m for Olympic votes. Inducements and sweeteners were endemic. Dick Pound, the former president of the World Anti-Doping Agency and then a member of the IOC who led the investigation into Salt Lake City, once stated that he had turned down a $1m bung in connection with a TV deal for the Olympics.

Admittedly, playing the game did not always produce the desired result. Before the vote for the 1996 Olympics, the Melbourne bid arranged for the Melbourne Symphony Orchestra to hold a special concert so the daughter of a South Korean IOC member could play piano with them, yet they were still crushed by Atlanta.

Such blatant behaviour is much harder to get away with nowadays. The IOCs reforms post Salt Lake City, including banning its members from visiting potential host cities before an Olympic vote, have stopped the worst abuses. It would be a surprise if it was revealed that there was anything wildly untoward about the bids for the 2008 Olympics, for which Beijing was always considered way out in front, or 2012 which has always been regarded as a straight and largely fair fight between London and Paris.

That said, the French police are investigating the bidding process for the Rio 2016 Olympics. And a trawl through the IOCs current, former, and honorary members does not inspire complete confidence.

The list includes such luminaries as Lamine Diack Papa Massatas father the former IAAF president, who is facing corruption charges in France which he denies, and was an influential IOC member between 1999 and 2013; along withSepp Blatter, the disgraced Fifa president, who was a prominent member for 16 years until 2015. Meanwhile, one of Blatters most loyal supporters, Issa Hayatou, one of two Fifa officials accused of taking bribes worth $1.5m to support the Qatar World Cup bid, remains an IOC member and denies the allegations against him.

Less well known, is the Kuwaiti Sheikh Ahmad al-Fahad al-Sabah, a hugely influential IOC and Fifa executive committee member, who was recently accused in parliament by the Tory MP Damian Collins of using the Olympic Council of Asia to buy votes. The OCA strongly denied the allegation.

That said, it would be churlish to not acknowledge the IOCs attempts to improve its voting procedures in recent years. They have tried. What the Guardians story shows, however, is that it is hard to completely protect such a lucrative and prized event as Olympics from corruption.

So what could be done? One radical suggestion is for voting for Olympics Games to be replaced by auctions, with the highest bidding country winning, providing it also met the appropriate levels of technical expertise. Rules could be put in place to ensure such events switch continents regularly, and to ensure that those ranked poorly on the corruption perceptions index were not able to enter the auction. Crucially such a proposal would ensure that any bid money could be directed towards the IOC, and presumably the sports themselves. As yet there is no widespread clamour for such proposals.

Meanwhile, the IOCs response to the latest allegations will be closely watched. After the Salt Lake City scandal rocked it to the core, it held an emergency general assembly in which Samaranch warned the organisation was now on trial and must root out all forms of inappropriate or unethical behaviour among our membership. Nearly two decades later, those words hold true once again.

Read more: https://www.theguardian.com/sport/2016/may/11/tokyo-olympic-games-2020-ioc-international-olympic-committee-corruption-bid-scandal

Its clunky in places and has some very suspect accents, but the new biopic is far from the only own goal in the Brazilian legends on-screen back catalogue

Originally scheduled to appear in time for the 2014 World Cup in Brazil, the long-delayed Pel: Birth of a Legend the first ever biopic of the soccer legend is finally being released. Co-directed by American brothers Jeff and Michael Zimbalist, and executive produced by Pel himself, the film unfolds like a superhero origin story crossed with a sporty riff on Slumdog Millionaire.

Its first half charts 10-year-old Pels hardscrabble existence alongside friends and family in the slums of So Paulo state; its second focuses on his rapid rise to prominence with the Brazil soccer squad, culminating in his teams victory at the 1958 World Cup in Sweden, when Pel was just 17. (Pel scored twice in a 5-2 win over the Swedes, here clumsily portrayed as a swaggering battalion of Aryan Terminators.)

Curiously, despite the films Brazilian setting, all its characters are fluent in English. This is presumably a ploy to enable the film to reach the widest possible audience, but it never stops being jarring. The weirdness factor only intensifies when Vincent DOnofrio, the burly American star of Netflixs Daredevil, pops up to portray Brazils under-pressure coach Vicente Feola. The actors Brazilian accent frequently strays, volubly and hilariously, into Al Pacino-in-Scarface territory.

Read more: http://www.theguardian.com/film/2016/may/10/pele-birth-of-a-legend-brazil-soccer-tribeca-film

Sean Parker knows a thing or two about sharing.

In 1999, he cofounded Napster, the notorious file-sharing service that became a household name as people discovered online music piracy for the first time. Parker later became the first president of Facebook, where, of course, more than a billion people regularly share links, media and status updates.

But sharing means something different to the 36-year-old entrepreneur now. He’s focused on creating a new way for the top minds fighting cancer to coordinate their efforts.

Parker is funding rigorous research into immunotherapy, a type of treatment that helps the body’s own immune system combat cancer. An alternative to radiation or chemo, immunotherapy has been shown to be effective on certain cancers, though criticisms have surfaced over the treatment’s cost and potential side effects.

Parker’s new initiative also provides a set of tools to researchers at several different centers to create a standardized exchange of information. In short, the new initiative is about creating data and distributing it, something Parker has always been interested in.

Of course, he’s changed quite a bit from his Napster days.

“There are a lot of people like myself who are frustrated that we’ve been working in consumer Internet for a long time, and that’s of dubious long-term significance to humanity,” Parker told The Huffington Post in an interview last week. “Maybe it makes sense to focus on things that are a bit more meaningful rather than doing the easy commercial stuff around building products for teenagers.”

On May 2, Parker was awarded the 2016 Pontifical Key Philanthropy Award at the Vatican for his contributions to immunotherapy research. HuffPost followed up with Parker to hear more about his latest initiative.

First, congratulations on the award. Would you ever have expected anything like this?

I don’t think you necessarily expect or even go into any of these things imagining that anyone’s going to recognize them — certainly not the Vatican. It’s really incredible.

It’s more important from the perspective of the scientists, researchers and the field of immunotherapy than it is for me personally. The field of immunotherapy has the potential to cure patients. Not even the potential — it’s already providing curative treatments for patients who otherwise weren’t treatable.

Anything that can be done to draw attention to the power of this specific approach is incredibly helpful to the field. And it’s also helpful for patients who need to be able to make an informed choice. They need to be able to go out there and say they want to receive immunotherapy. 

Why did you become particularly interested in life sciences?

There’s a general movement amongst Silicon Valley entrepreneurs toward life sciences. There’s this feeling that computations and big data are finally at a point where they’re converging with the work that’s being done in the life sciences, and that convergence moment is driving a lot of enthusiasm.

One would expect to have a lot of interest in life science. We’re presumably biological beings. And we’re all faced with our own mortality. This is something that we should be really interested in.

I think people coming from a computer science or an engineering background in Silicon Valley may not feel that their skills were applicable to the field a decade ago, and maybe that applicability is more obvious now. There are a lot of people like myself who are frustrated that we’ve been working in consumer Internet for a long time, and that’s of dubious long-term significance to humanity. Maybe it makes sense to focus on things that are a bit more meaningful rather than doing the easy commercial stuff around building products for teenagers.

So much of your mission seems to be based on connecting scientists and fostering collaboration. It strikes me as a little ironic in this era of 24/7 connectivity and communication.

I think it’s widely understood within the life sciences world that collaboration doesn’t take place between centers, or even between researchers as efficiently as it should. One piece of that is data sharing. It’s not as straightforward as getting scientists to talk to one another. They do that. They go to conferences, they email one another, they ask questions.

But the problems definitely run deeper than just getting them communicating. If you take the problem of data sharing for instance, data sharing — in order to share data, you need to first be, let’s say, measuring the same thing. You need to be recording the same data in multiple clinical trials, in multiple sites, across patients. You need to have standardized ways of measuring the data.

We’re all faced with our own mortality. This is something that we should be really interested in.” Sean Parker

If you’re not measuring the same thing, then it’s not really shareable. That gets at systemic problems with the life sciences world that an outsider coming from another field would initially have a hard time understanding, as I certainly did when I started working in this industry. It’s only logical that researchers working on the same problem across many different institutions would be collaborating and taking part in data sharing. In theory that should take place. But practically it’s difficult.

When you have a consortium, you make sure people have the same tools available, so they can measure the same things. One of the advantages of having a consortium is that you have six centers effectively operating under the same framework. You’re able to collect samples in the same way, then you’re able to interrogate those samples or conduct tests at different points of time.

The Washington Post via Getty Images
The housing case for the IBM Watson computer, which can help doctors diagnose and treat illnesses.

There’s been so much talk about how machine learning and artificial intelligence could improve health care. IBM Watson, for example, says it can connect doctors to research like never before and help develop innovative treatments. What do you think of that model?

It’s hard to speak specifically to IBM Watson because it feels a little bit like a marketing effort. In life sciences, we’re dealing with systems that ultimately, if we had a perfect description of them that was perfectly defined or characterized, then we could build a system and we could do more of the research in a computer system. But we’re not at that point yet. There are so many holes in the model of what’s in the immune system. It’s just incredible how little is known about things where it seems like we already know so much.

I think that’s everyone’s dream — if we had systems that were really good models of what’s happening in the human body in all of its complexity. It would be a heck of a lot easier to interrogate those systems than to do this work in humans. Talk to biologists, they’ll tell you we’re a lot farther away from that than the computer scientists will tell you.

I think personally I was shocked by the complexity or the number of variables that are currently unknown, or interactions that are unknown. It’s always a tradeoff between doing the research that you know will be valuable in humans immediately versus doing the long-term discovery efforts that will speed up the process of learning in the future.

This interview has been edited and condensed for clarity.

Read more: http://www.huffingtonpost.com/2016/05/04/sean-parker-interview-cancer-research_n_9890054.html